Avoro Capital Advisors LLC Design Therapeutics, Inc. Transaction History

Avoro Capital Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$5.5 - $9.77 $6.75 Million - $12 Million	1,227,778 Added 54.03%	3,500,000 $20.2 Million
Q4 2022 Feb 14, 2023	BUY	$7.86 - $17.2 $393,000 - $860,000	50,000 Added 2.25%	2,272,222 $23.3 Million
Q1 2022 May 16, 2022	BUY	$11.17 - $20.89 $6.55 Million - $12.2 Million	586,122 Added 35.82%	2,222,222 $35.9 Million
Q4 2021 Feb 14, 2022	BUY	$13.64 - $21.41 $2.29 Million - $3.59 Million	167,782 Added 11.43%	1,636,100 $35 Million
Q1 2021 May 17, 2021	BUY	$29.52 - $41.49 $43.3 Million - $60.9 Million	1,468,318 New	1,468,318 $39.7 Million

102

31M

2.3K

16.5K

Ticker DSGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,807,900
Market Cap $347M
Description
Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ syste...

Get notified when there are updates to the investment portfolio of Avoro Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Avoro Capital Advisors LLC with notifications on news.